Ramón Gomis - Concepedia

Author

Ramón Gomis

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

Gomis R., R GOMIS, R Gomis, R. GOMIS, R. Gomis, R. R. Gomis, RAMON GOMIS, Ramon Gomis, Ramón Gomis, Ramón Gomis

270

Publications

21.7K

Citations

H-Index

174

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Universitat de Barcelona Hospital Clínic de Barcelona Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Hospital Del Mar

About

Ramón Gomis is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	73	7K
2	Health Sciences	19	27	3.5K
3	Engineering	2	2	169
4	Arts	1	1	50
5	Natural Sciences	1	1	16

Ramón Gomis

142

Publications

20.4K

Citations

H-Index

Page 1

	Year	Citations
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Hendrik Lehnert, Jens Brøchner‐Mortensen, Ramón Gomis, New England Journal of Medicine	2001	2.9K
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis, The Lancet Metabolic SyndromeDisease ManagementDiabetes ManagementPreventive MedicineHealth Policy	2002	2.5K
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes]. Hans‐Henrik Parving, Hendrik Lehnert, Jens Brøchner‐Mortensen, PubMed	2001	2.5K
Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance Jean‐Louis Chiasson, Robert G. Josse, Ramón Gomis, JAMA	2003	1.6K
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Philip Home, Stuart Pocock, Henning Beck‐Nielsen, The Lancet Open-label TrialDiabetes ManagementCardiovascular DiseaseCardiovascular OutcomesMedicine	2009	1.4K
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study Federico Soriguer, Albert Goday, Anna Bosch-Comas, Diabetologia	2011	1.1K
Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis Philip Home, Stuart Pocock, Henning Beck‐Nielsen, New England Journal of Medicine	2007	762
Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes Bo Åhrén, Ramón Gomis, Eberhard Standl, Diabetes Care	2004	485
Improvement of Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Melanie J. Davies, F. Storms, S.D. Shutler, Diabetes Care	2005	311
4-Hydroxyisoleucine: A Novel Amino Acid Potentiator of Insulin Secretion Yves Sauvaire, Pierre Petit, Christophe Broca, Diabetes	1998	288

Page 1